The published data on the beneficial effects of lithium on tau pathology have resulted in the performance of several clinical studies of lithium as a potential treatment for Alzheimer's disease [14], [15]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.